Mayne Pharma Group Limited (MYX.AX)

AUD 4.85

(-2.02%)

Total Liabilities Summary of Mayne Pharma Group Limited

Mayne Pharma Group Limited's latest annual total liabilities in 2024 was 688.98 Million AUD , up 12.25% from previous year.
Mayne Pharma Group Limited's latest quarterly total liabilities in 2024 FY was 689.04 Million AUD , up 12.26% from previous quarter.
Mayne Pharma Group Limited reported annual total liabilities of 613.77 Million AUD in 2023, down -19.76% from previous year.
Mayne Pharma Group Limited reported annual total liabilities of 764.88 Million AUD in 2022, up 8.26% from previous year.
Mayne Pharma Group Limited reported quarterly total liabilities of 689.04 Million AUD for 2024 FY, up 12.26% from previous quarter.
Mayne Pharma Group Limited reported quarterly total liabilities of 688.98 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Mayne Pharma Group Limited (2024 - 2007)

Historical Annual Total Liabilities of Mayne Pharma Group Limited (2024 - 2007)

Year	Total Liabilities	Total Liabilities Growth
2024	688.98 Million AUD	12.25%
2023	613.77 Million AUD	-19.76%
2022	764.88 Million AUD	8.26%
2021	706.55 Million AUD	-11.67%
2020	799.9 Million AUD	28.55%
2019	622.26 Million AUD	4.52%
2018	595.35 Million AUD	-0.04%
2017	595.61 Million AUD	-48.19%
2016	1.14 Billion AUD	456.03%
2015	206.74 Million AUD	94.04%
2014	106.54 Million AUD	-5.29%
2013	112.5 Million AUD	382.16%
2012	23.33 Million AUD	-20.91%
2011	29.5 Million AUD	-35.3%
2010	45.59 Million AUD	13654.27%
2009	331.53 Thousand AUD	30.09%
2008	254.85 Thousand AUD	-74.42%
2007	996.15 Thousand AUD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	605.91 Million AUD	0.0%
2024 FY	689.04 Million AUD	12.26%
2024 Q4	688.98 Million AUD	0.0%
2023 FY	613.77 Million AUD	-19.76%
2023 Q4	613.77 Million AUD	0.0%
2023 Q2	695.54 Million AUD	0.0%
2022 Q2	733.51 Million AUD	0.0%
2022 Q4	745.99 Million AUD	0.0%
2022 FY	764.88 Million AUD	8.26%
2021 Q2	726.85 Million AUD	0.0%
2021 Q4	706.55 Million AUD	0.0%
2021 FY	706.55 Million AUD	-11.67%
2020 FY	799.9 Million AUD	28.55%
2020 Q4	799.9 Million AUD	0.0%
2020 Q2	791.25 Million AUD	0.0%
2019 Q2	715.08 Million AUD	0.0%
2019 FY	622.26 Million AUD	4.52%
2019 Q4	622.26 Million AUD	0.0%
2018 Q2	596.85 Million AUD	0.0%
2018 Q4	595.35 Million AUD	0.0%
2018 FY	595.35 Million AUD	-0.04%
2017 Q2	577.28 Million AUD	0.0%
2017 FY	595.61 Million AUD	-48.19%
2017 Q4	595.61 Million AUD	0.0%
2016 Q4	1.14 Billion AUD	0.0%
2016 FY	1.14 Billion AUD	456.03%
2016 Q2	249.05 Million AUD	0.0%
2015 FY	206.74 Million AUD	94.04%
2015 Q2	139.93 Million AUD	0.0%
2015 Q4	206.74 Million AUD	0.0%
2014 Q2	122.82 Million AUD	0.0%
2014 Q4	106.54 Million AUD	0.0%
2014 FY	106.54 Million AUD	-5.29%
2013 Q4	112.5 Million AUD	0.0%
2013 Q2	82.5 Million AUD	0.0%
2013 FY	112.5 Million AUD	382.16%
2013 Q3	112.5 Million AUD	36.36%
2012 FY	23.33 Million AUD	-20.91%
2012 Q4	23.33 Million AUD	0.0%
2011 Q4	29.5 Million AUD	0.0%
2011 FY	29.5 Million AUD	-35.3%
2010 Q4	45.59 Million AUD	0.0%
2010 FY	45.59 Million AUD	13654.27%
2009 Q4	331.53 Thousand AUD	0.0%
2009 FY	331.53 Thousand AUD	30.09%
2008 FY	254.85 Thousand AUD	-74.42%
2008 Q4	254.85 Thousand AUD	0.0%
2007 Q4	996.15 Thousand AUD	0.0%
2007 FY	996.15 Thousand AUD	0.0%

Peer Total Liabilities Comparison of Mayne Pharma Group Limited

Name	Total Liabilities	Total Liabilities Difference
Firebrick Pharma Limited	291.06 Thousand AUD	-236609.852%